Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid tumors with activating HER2 alterations: A phase I basket trial Meeting Abstract
| Authors: | Li, B. T.; Li, T.; Johnson, M. L.; Waqar, S. N.; Zhu, V. W.; Ou, S. H. I.; Lin, J. J.; Wang, D.; Shapiro, G.; Wang, J. S. Z.; Liu, D.; Ye, Y.; Kosar, H.; Hee, A.; Berk, G.; Zhang, S.; Wang, J.; Patel, M. R. |
| Abstract Title: | Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid tumors with activating HER2 alterations: A phase I basket trial |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 167s |
| Language: | English |
| ACCESSION: | WOS:000560368301406 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.3510 |
| Notes: | Meeting Abstract: 3510 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
